Skip to main content

Table 3 Frequency of adverse drug events observed during MDR treatment, Pham Ngoc Thach hospital, 2010

From: Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam

Type of adverse eventa

Total

Mildb

Moderatec

Severed

No information

n

%

Total

226

100.0

78

32

25

91

Arthralgia/joint pain

81

35.8

25

16

7

33

Gastrointestinal

32

14.2

18

2

0

12

Ototoxicity

19

8.4

8

3

4

4

Cutaneous reaction

15

6.6

4

4

0

7

Giddiness

13

5.8

2

1

0

10

Psychiatric symptoms

10

4.4

5

1

3

1

Hepatitis

7

3.1

1

2

4

0

Peripheral neuropathy

7

3.1

3

1

0

3

Renal toxicity

5

2.2

2

0

3

0

Visual symptoms

5

2.2

4

0

0

1

Insomnia

5

2.2

0

0

0

5

Hypothyroidism

3

1.3

0

2

1

0

Central nervous system

1

0.4

0

0

0

1

Others

23

10.2

6

0

3

14

  1. a An individual patient could have had more than 1 adverse event during the MDR treatment period
  2. b Mild: the drug was continued at the same dose, with or without ancillary drug prescribed, e.g., reassurance
  3. c Moderate: drug was continued at a reduced dose, with an ancillary drug prescribed
  4. d Severe: drug was changed or stopped and/or all medical treatment was stopped